Pharmaceutical Formulation Comprising Donepezil
    1.
    发明申请
    Pharmaceutical Formulation Comprising Donepezil 审中-公开
    药物制剂包含多奈哌齐

    公开(公告)号:US20100055171A1

    公开(公告)日:2010-03-04

    申请号:US12374786

    申请日:2007-06-29

    IPC分类号: A61K9/48 A61K31/445 A61K9/28

    摘要: The present invention relates to a pharmaceutical composition comprising 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one, herein after referred to as Donepezil, or a pharmaceutically acceptable salt thereof, for treating of Alzheimer's disease and senile dementia. The present invention also relates to a manufacturing process for the preparation of Donepezil tablets containing and retaining polymorphic Form I of Donepezil hydrochloride. This composition also discloses the use of the excipients that ensure adequate flowability of a dry blend as well as required content uniformity and drug release rate of the final product.

    摘要翻译: 本发明涉及包含2,3-二氢-5,6-二甲氧基-2 - [[1-(苯基甲基)-4-哌啶基]甲基] -1H-茚-1-酮的药物组合物 作为多奈哌齐,或其药学上可接受的盐,用于治疗阿尔茨海默病和老年痴呆症。 本发明还涉及制备多奈哌齐片剂的制备方法,所述多奈哌齐片剂含有和保留盐酸多奈哌齐的多晶型I。 该组合物还公开了确保干混合物的充分流动性以及所需含量均匀性和最终产品的药物释放速率的赋形剂的用途。